Back to Search Start Over

Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study

Authors :
Antonio Pizzolante
Mario Capasso
Alessandro Perrella
Dario Bruzzese
Pellegrino Cerino
Luigi Atripaldi
Paolo A. Ascierto
Biancamaria Pierri
Palmiero Volzone
Gianfranco Brambilla
Massimo Zollo
Maria Triassi
Carlo Buonerba
Annachiara Coppola
Cerino, P.
Coppola, A.
Volzone, P.
Pizzolante, A.
Pierri, B.
Atripaldi, L.
Zollo, M.
Capasso, M.
Ascierto, P. A.
Triassi, M.
Brambilla, G.
Perrella, A.
Bruzzese, D.
Buonerba, C.
Source :
Future Science OA
Publication Year :
2021

Abstract

The Italian municipality of Ariano Irpino (Avellino, Campania, Italy) was locked down by the regional authorities from March until April 2020 after several citizens tested positive for SARS coronavirus 2 (SARS-CoV-2). A serological mass screening campaign targeting the Ariano Irpino population using the Roche Cobas Elecsys anti-SARS-CoV-2 assay was organized by the Zoo-Prophylactic Institute of Southern Italy (Portici, Italy) and conducted in cooperation with the Local Health Unit (Azienda Sanitaria Locale – ASL – Avellino, Avellino, Italy), the Department of Public Health of University Federico II (Naples, Italy) and Department of Health Services of Azienda Ospedaliera dei Colli-Cotugno and Monaldi Hospital (Naples, Italy) in May 2020. A total of 13,218 asymptomatic individuals were reviewed in this analysis. A total of 738 citizens tested positive for anti-SARS-CoV-2 antibodies (398 females, 340 males). The overall prevalence in the sample was 5.6% (95% CI: 5.2–6.0). Among seropositive citizens, 101 cases tested positive on RT-PCR (0.76% of the overall population). Among citizens aged 14–18, 18–65 and >65 years, the seroprevalence was equal to 6.1 (95% CI: 4.1–8.7), 5.6 (95% CI: 5.1–6.1) and 4% (95% CI: 3.3–4.8), respectively. In the pediatric cohort (<br />Lay abstract A mass screening campaign targeting the Ariano Irpino population in Italy, including a total of 13,218 asymptomatic individuals, showed that 5.6% of the tested individuals had antibodies against the virus responsible for COVID-19 in the blood. Among citizens aged 65 years, the proportion of positive individuals was equal to 13, 6.1, 5.6 and 4%, respectively. These asymptomatic individuals, who were identified by a simple blood draw using an inexpensive test (costing only a few euros), could inadvertently spread the infection. A serological-based screening strategy could therefore be a cost-effective public health intervention.

Details

Language :
English
Database :
OpenAIRE
Journal :
Future Science OA
Accession number :
edsair.doi.dedup.....be7faf7af2b3be939a64abb5705c07df